Market Place
Sourcing Support
Oncocyte Renamed Insight Molecular, Moves HQ To Nashville
17 Jun 2025 //
GLOBENEWSWIRE
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
07 May 2025 //
GLOBENEWSWIRE
Oncocyte to Attend Needham Healthcare Conference
02 Apr 2025 //
GLOBENEWSWIRE
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
24 Mar 2025 //
GLOBENEWSWIRE
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
18 Mar 2025 //
GLOBENEWSWIRE
Oncocyte to Attend BTIG MedTech & Life Sciences Conference
11 Feb 2025 //
GLOBENEWSWIRE
Oncocyte Prices $29.1 Million Equity Offering
10 Feb 2025 //
GLOBENEWSWIRE
Oncocyte Appoints Dr. Paul as Consulting Chief Medical Officer
08 Jan 2025 //
GLOBENEWSWIRE
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
06 Jan 2025 //
GLOBENEWSWIRE
Oncocyte to Host Investor Meetings During "J.P. Morgan Week"
09 Dec 2024 //
GLOBENEWSWIRE
Oncocyte Shows Liquid Biopsy Potential for Brain Tumors
04 Dec 2024 //
GLOBENEWSWIRE
Oncocyte Assay Detects Kidney Transplant Rejection Than Protocols
02 Dec 2024 //
GLOBENEWSWIRE
Oncocyte Reports Progress, Targets 20 Transplant Centers by 2025
12 Nov 2024 //
GLOBENEWSWIRE
Oncocyte To Announce Q3 2024 Financial Results on Nov. 12
06 Nov 2024 //
GLOBENEWSWIRE
Oncocyte Participates In LD Micro Main Event XVII Conference
16 Oct 2024 //
GLOBENEWSWIRE
Oncocyte’s DetermaIO Response to Atezolizumab in Ph 2 Trial
08 Oct 2024 //
GLOBENEWSWIRE
Oncocyte Raises $10.2M Via At-Market Private Placement
03 Oct 2024 //
GLOBENEWSWIRE
Oncocyte Signs Leading Transplant Centers in US and Germany
03 Oct 2024 //
GLOBENEWSWIRE
Oncocyte`s VitaGraft Kidney Used In New Case Series Study
12 Aug 2024 //
GLOBENEWSWIRE
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08 Aug 2024 //
GLOBENEWSWIRE
Oncocyte Announces August Investor Conferences Participation
05 Aug 2024 //
GLOBENEWSWIRE
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 Aug 2024 //
GLOBENEWSWIRE
Oncocyte appoints Andrea James as Chief Financial Officer
17 Jun 2024 //
GLOBENEWSWIRE
OncoCyte`s Innovative Approach: Potential in Precision Diagnostics
05 Jun 2024 //
ACCESSWIRE
Oncocyte VitaGraft Kidney Study Published In NEJM
30 May 2024 //
GLOBENEWSWIRE
Oncocyte Reports First Quarter 2024 Financial Results
15 May 2024 //
GLOBENEWSWIRE
Oncocyte to Announce First Quarter 2024 Financial Results
13 May 2024 //
GLOBENEWSWIRE
Oncocyte Reports Full Year 2023 Financial Results
12 Apr 2024 //
GLOBENEWSWIRE
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
11 Apr 2024 //
GLOBENEWSWIRE
Oncocyte $15.8M Private Placement Priced Per Nasdaq Rules
11 Apr 2024 //
GLOBENEWSWIRE
Oncocyte: Q4 & Full Year 2024 Financial Results Financials
09 Apr 2024 //
GLOBENEWSWIRE
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
06 Dec 2023 //
GLOBENEWSWIRE
Oncocyte to Announce Third Quarter 2023 Financial Results
03 Nov 2023 //
GLOBENEWSWIRE
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Conference
06 Sep 2023 //
ACCESSWIRE
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
25 Jul 2023 //
GLOBENEWSWIRE
Oncocyte Announces 1-For-20 Reverse Stock Split
24 Jul 2023 //
GLOBENEWSWIRE
Oncocyte Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Oncocyte To Announce First Quarter 2023 Financial Results
27 Apr 2023 //
GLOBENEWSWIRE
Oncocyte Presents New Data at AACR
18 Apr 2023 //
GLOBENEWSWIRE
Oncocyte Announces Reduction in Force
12 Apr 2023 //
GLOBENEWSWIRE
Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study
07 Apr 2023 //
GLOBENEWSWIRE
Oncocyte Pricing of $13.86 Million Public Offering of Common Stock
03 Apr 2023 //
GLOBENEWSWIRE
Oncocyte Reports Preliminary 4Q & 2022 Financial Results
31 Mar 2023 //
GLOBENEWSWIRE
Oncocyte Announces Date Change for Fourth Quarter & Full Year 2022 Earnings Call
29 Mar 2023 //
GLOBENEWSWIRE
Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results
15 Mar 2023 //
GLOBENEWSWIRE
Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
02 Mar 2023 //
GLOBENEWSWIRE
Oncocyte Completes Razor Genomics Transaction
22 Feb 2023 //
GLOBENEWSWIRE
Oncocyte Announces Initiatives to Focus Corporate Strategy
16 Dec 2022 //
GLOBENEWSWIRE
Oncocyte Announces Executive Leadership Changes
30 Nov 2022 //
GLOBENEWSWIRE
Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its BOD
30 Nov 2022 //
GLOBENEWSWIRE
Oncocyte to Announce Third Quarter 2022 Financial Results
27 Oct 2022 //
GLOBENEWSWIRE
Oncocyte Announces Unanimous Recommendation from the Advisory Panel
07 Sep 2022 //
GLOBENEWSWIRE
Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth
31 Aug 2022 //
GLOBENEWSWIRE
Oncocyte Announces Five-Year VA Contract for DetermaRx
30 Aug 2022 //
GLOBENEWSWIRE
Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member
01 Aug 2022 //
GLOBENEWSWIRE
Oncocyte to Announce Second Quarter 2022 Financial Results
27 Jul 2022 //
GLOBENEWSWIRE
Oncocyte Announces Market Entry and Early Adopter Program
13 Jul 2022 //
GLOBENEWSWIRE
Oncocyte Presents DetermaIO Data in Podium Presentation at ESMO
06 Jul 2022 //
GLOBENEWSWIRE
Oncocyte Presents DetermaIO` Data at ASCO on Clinical Use of Immunotherapy
26 May 2022 //
GLOBENEWSWIRE
Oncocyte Reports First Quarter 2022 Financial Results
11 May 2022 //
GLOBENEWSWIRE
